SPUTNIK V

About:

• If approved by the Drug Controller General of India (DCGI), Sputnik V would be the third vaccine to be made available in India after the Serum Institute of India’s Covishield and Bharat Biotech’s Covaxin.
  
  
• Sputnik V, developed by Russia’s Gamaleya Research Institute of Epidemiology and Microbiology, claims to be one of the three vaccines in the world with efficacy of over 90%.
  
  
• the vaccine supplies for the global market will be produced by the Russian Direct Investment Fund (RDIF) international partners in India, Brazil, China, South Korea and other countries.